Table 1.
Key feature | CPADs | CPGs |
---|---|---|
| ||
State of field and testing technology | Early in assessment of the field and testing technology | Later in assessment of the field and testing technology |
State of the evidence | Insufficient evidence to evaluate benefits and harms of testing | Sufficient evidence to evaluate benefits and harms of testing |
Product(s) | (1) Advice for clinicians based largely on expert judgment about the potential benefits and harms of testing, the uncertainties in current evidence, and the trade-offs for different approaches (2) Recommendations for research to improve clinical test use |
Recommendations for clinical practice based on evaluation of the evidence, with strength of recommendations determined by quality of evidence |
Updating | Annual review of relevant evidence with revision of CPAD or decision to proceed to CPG | Appropriate plan for updating, as determined after CPG development |
CPAD clinical practice advisory document, CPG clinical practice guideline.